Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Billiontoone Inc. maintains 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct examiners and 3 distinct art units, indicating a broad distribution of technical review for the current portfolio. This arrangement suggests that the company's filings cover several different specialized areas within the biotechnology sector, each requiring engagement with a different unit at the office.
The busiest examiner, VANORE, DAVID A, is managing 1 busiest examiner pending office action. With 3 pending office actions and 3 distinct examiners, the workload is perfectly distributed, with each examiner handling a single matter. For a practitioner, this means that every active application requires a unique relationship with a different examiner, and there is no central figure overseeing the majority of the portfolio's prosecution.
The use of 3 distinct art units for 3 pending office actions highlights the technical diversity of the company's current patent efforts. Since VANORE, DAVID A only handles 1 busiest examiner pending office action, the prosecution strategy must be tailored to three different individual styles and three different sets of art unit policies. This decentralized structure requires careful coordination to ensure that the company's overall patent goals are met across these varied technical fields.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (33%) |
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VANORE, DAVID A | 1 | 88.8% | +7.6% |
| ZHANG, KAIJIANG | 1 | 77.2% | +34.3% |
| CASH, KAILEY ELIZABETH | 1 | 28.6% | +64.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18943785 | TARGET-ASSOCIATED MOLECULES FOR CHARACTERIZATION ASSOCIATED WITH BIOLOGICAL TARGETS | VANORE, DAVID A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17702708 | FRAGMENT ANALYSIS FOR QUANTITATIVE DIAGNOSTICS OF BIOLOGICAL TARGETS | CASH, KAILEY ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17952098 | QUALITY CONTROL TEMPLATES ENSURING VALIDITY OF SEQUENCING-BASED ASSAYS | ZHANG, KAIJIANG | — |
| 17702708 | FRAGMENT ANALYSIS FOR QUANTITATIVE DIAGNOSTICS OF BIOLOGICAL TARGETS | CASH, KAILEY ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 2878 | 1 |
| 1684 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18943785 | TARGET-ASSOCIATED MOLECULES FOR CHARACTERIZATION ASSOCIATED WITH BIOLOGICAL TARGETS | VANORE, DAVID A | 2878 | §112 | Non-Final OA | — | Pending | Nov 11, 2024 |
| 17952098 | QUALITY CONTROL TEMPLATES ENSURING VALIDITY OF SEQUENCING-BASED ASSAYS | ZHANG, KAIJIANG | 1684 | §102 | Non-Final OA | — | Pending | Sep 23, 2022 |
| 17702708 | FRAGMENT ANALYSIS FOR QUANTITATIVE DIAGNOSTICS OF BIOLOGICAL TARGETS | CASH, KAILEY ELIZABETH | 1683 | §103§112DP | Final Rejection | — | Pending | Mar 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBilliontoone Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
David A Vanore has the most, with 1 of Billiontoone Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
